Genotypic and Clinical Heterogeneity Amongst NCCN Favorable-Risk Acute Myeloid Leukemias

被引:0
|
作者
Seegmiller, Adam
Strickland, Stephen A.
Shaver, Aaron C.
Daber, Robert D.
Byrne, Michael
Ferrell, P. B.
Head, David R.
Mohan, Sanjay R.
Vnencak-Jones, Cindy L.
Zutter, Maly M.
Savona, Michael R.
机构
[1] Vanderbilt Univ, Sch Med, Nashville, TN 37212 USA
[2] BioReference Labs, Elmwood Pk, NJ USA
关键词
D O I
暂无
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
1504
引用
收藏
页码:375A / 375A
页数:1
相关论文
共 50 条
  • [41] Outcome with Intensive Chemotherapy vs Hypomethylating Agent-Based Induction Strategies in Patients Older Than 70 Years with Newly Diagnosed, Favorable-Risk Acute Myeloid Leukemia
    Ball, Somedeb
    Jain, Akriti G.
    Al Ali, Najla
    Hayden, Alexander
    Swoboda, David M.
    Aguirre, Luis E.
    Sallman, David A.
    Padron, Eric
    Sweet, Kendra
    Lancet, Jeffrey E.
    Watts, Justin
    Pollyea, Daniel A.
    Komrokji, Rami S.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 : S293 - S293
  • [42] Mutational Signature Correlates with Proliferative Phenotype in NCCN Poor-Risk Acute Myeloid Leukemia
    Shaver, Aaron C.
    Juskevictus, Ridas
    Dabei, Robert D.
    Strickland, Stephen A.
    Ferrell, Paul B.
    Byrne, Michael
    Mohan, Sanjay R.
    Vnencak-Jones, Cindy L.
    Zutter, Mary M.
    Kim, Annette S.
    Seegmiller, Adam
    Savona, Michael R.
    Head, David R.
    LABORATORY INVESTIGATION, 2017, 97 : 377A - 377A
  • [43] Mutational Signature Correlates with Proliferative Phenotype in NCCN Poor-Risk Acute Myeloid Leukemia
    Shaver, Aaron C.
    Juskevicius, Ridas
    Dabei, Robert D.
    Strickland, Stephen A.
    Ferrell, Paul B.
    Byrne, Michael
    Mohan, Sanjay R.
    Vnencak-Jones, Cindy L.
    Zutter, Maly M.
    Kim, Annette S.
    Seegmiller, Adam
    Savona, Michael R.
    Head, David R.
    MODERN PATHOLOGY, 2017, 30 : 377A - 377A
  • [44] Clinical impact of leukemic blast heterogeneity at diagnosis in cytogenetic intermediate-risk acute myeloid leukemia
    Hoffmann, Marianne Hutchings
    Klausen, Tobias Wirenfeldt
    Boegsted, Martin
    Larsen, Steffen Falgreen
    Schmitz, Alexander
    Leinoe, Eva Birgitte
    Schmiegelow, Kjeld
    Hasle, Henrik
    Bergmann, Olav Jonas
    Sorensen, Suzette
    Nyegaard, Mette
    Dybkaer, Karen
    Johnsen, Hans Erik
    CYTOMETRY PART B-CLINICAL CYTOMETRY, 2012, 82B (03) : 123 - 131
  • [45] Evaluation of Gemtuzumab Ozogamicin and Anthracycline Dosing for Favorable Risk Acute Myeloid Leukemia
    Mort, Joseph F.
    Brighton, David
    Dibenedetto, Samantha
    Wells, Leah
    Clark, Stephen M.
    Reid, Justin
    Patel, Imari
    Jackson, Clayton
    Yelvington, Bradley
    Miller, Ryan
    Perciavalle, Matthew
    Walsh, Katherine
    Wolfe, Heather
    Locke, Susan C.
    Zeidner, Joshua F.
    Duong, Vu H.
    Reed, Daniel R.
    Dholaria, Bhagirathbhai
    Leblanc, Thomas W.
    Keng, Michael
    Horton, Bethany
    El Chaer, Firas
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2025, 114 (03) : 481 - 494
  • [47] BIOLOGICAL, GENETIC AND CLINICAL CHARACTERIZATION OF CHILDHOOD ACUTE MYELOID LEUKEMIAS WITH MLL GENE REARRANGEMENTS
    Ruranska, Iwona
    Gaworczyk, Anna
    Meyer, Claus
    Malinowska, Iwona
    Ussowicz, Marek
    Haus, Olga
    Koltan, Andrzej
    Derwich, Katarzyna
    Niedzwiecki, Maciej
    Trelinska, Joanna
    Kamienska, Elzbieta
    Wieczorek, Maria
    Muszynska-Roslan, Katarzyna
    Sobol, Grazyna
    Balwierz, Walentyna
    Karolczyk, Grazyna
    Badowska, Wanda
    Winnicka, Dorota
    Kowalczyk, Jerzy
    Grzeszczak, W.
    Kowarz, Eric
    Marschalek, Rolf
    Szczepanski, Tomasz
    PEDIATRIC BLOOD & CANCER, 2011, 57 (05) : 772 - 772
  • [48] Tobacco Smoke Exposure and the Risk of Childhood Acute Lymphoblastic and Myeloid Leukemias by Cytogenetic Subtype
    Metayer, Catherine
    Zhang, Luoping
    Wiemels, Joseph L.
    Bartley, Karen
    Schiffman, Joshua
    Ma, Xiaomei
    Aldrich, Melinda C.
    Chang, Jeffrey S.
    Selvin, Steve
    Fu, Cecilia H.
    Ducore, Jonathan
    Smith, Martyn T.
    Buffler, Patricia A.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2013, 22 (09) : 1600 - 1611
  • [49] High Mitophagy and Low Glycolysis Predict Better Clinical Outcomes in Acute Myeloid Leukemias
    Salwa, Amreen
    Ferraresi, Alessandra
    Vallino, Letizia
    Maheshwari, Chinmay
    Moia, Riccardo
    Gaidano, Gianluca
    Isidoro, Ciro
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (21)
  • [50] Discussion on reply to Foley et al., 'Acute myeloid leukemia with t(14;21) involving RUNX1 and SYNE2: A novel favorable-risk translocation?'
    Mannis, Gabriel N.
    CANCER GENETICS, 2018, 220 : 77 - 78